48.30 USD
▼-1.94-3.86%
盘后 48.77 0.00%
2026-11-19
市值
$4.64B
市盈率
—
EPS
-1.31
股息率
—
52 周区间
22.59 – 68.73
成交量
1.79M
Beta
1.12
目标价
73.43
52W 低 22.5952W 高 68.73
价格走势
公司简介
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company’s products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urin...